Zobrazeno 1 - 10
of 17
pro vyhledávání: '"P J, Van Veldhuizen"'
Autor:
Angela H. A. M. van Hoek, Janieke N. J. van Veldhuizen, Ingrid Friesema, Claudia Coipan, John W. A. Rossen, Indra L. Bergval, Eelco Franz
Publikováno v:
BMC Genomics, Vol 20, Iss 1, Pp 1-14 (2019)
Abstract Background Wild birds, in particular pigeons are considered a natural reservoir for stx 2f-carrying E. coli. An extensive comparison of isolates from pigeons and humans from the same region is lacking, which hampers justifiable conclusions o
Externí odkaz:
https://doaj.org/article/0d0cbf05e9884accac2d0f348d34abf7
Autor:
Joseph M. Unger, Katherine Griffin, Gary W. Donaldson, Karen M. Baranowski, Margorie J. Good, Eunicia Reburiano, Maha Hussain, Paul J. Monk, Peter J. Van Veldhuizen, Michael A. Carducci, Celestia S. Higano, Primo N. Lara, Catherine M. Tangen, David I. Quinn, James L. Wade, III, Nicholas J. Vogelzang, Ian M. Thompson, Jr, Carol M. Moinpour
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-10 (2018)
Abstract Background SWOG S0421 was a large randomized trial comparing docetaxel/prednisone plus placebo (DPP) to docetaxel/prednisone plus atrasentan over 12 cycles for patients with metastatic castration-resistant prostate cancer (mCRPC). The curren
Externí odkaz:
https://doaj.org/article/b886bdc66c744576bec9567dfc8ec7ee
Autor:
Chao H Huang, Stephen K Williamson, Prakash eNeupane, Sarah A Taylor, Ace eAllen, Nora J Smart, Adelina M Uypeckcuat, Sarah eSpencer, Jo eWick, Holly eSmith, Peter J Van Veldhuizen, Karen eKelly
Publikováno v:
Frontiers in Oncology, Vol 5 (2016)
Background: Insulin-like growth factor 1 receptor (IGF-1R) regulates cell growth, proliferation and apoptosis. Adenocarcinoma and never-smokers have a higher expression of IGF-1R, which is associated with worse overall survival. Dalotuzumab-MK0646 (D
Externí odkaz:
https://doaj.org/article/d6ef07d5512e44d4ba18480f63ccc3f9
Autor:
Chao H Huang, Jo eWick, Gurusingham (Sitta) eSittampalam, Victor Sanjit eNirmalanandhan, Apar eGanti, Stephen K Williamson, Prakash C Neupane, Andrew eGodwin, Sarah eSchmitt, Nora J Smart, Sarah eSpencer, Peter J Van Veldhuizen
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Abstract Background: SCLC, a variant of lung cancer marked by early metastases, accounts for 13% of all lung cancers diagnosed in US. Despite high response rates to treatment, it is an aggressive disease with a median survival of 9-11 months for pati
Externí odkaz:
https://doaj.org/article/c099dbe53c4d4a3896caacf2d951b043
Autor:
Mark J. Noble, Raj Sadasivan, R. Morgan, Ronald L. Stephens, Mark S. Austenfeld, Scott Jennings, P J Van Veldhuizen
Publikováno v:
Journal of Urology. 150:126-131
Previous reports have shown that Her-2/neu oncogene expression in human breast cancer and ovarian cancer may be associated with poorer prognosis. We report the expression of Her-2/neu on fresh samples of known prostatic adenocarcinoma but not on thos
Publikováno v:
The Prostate. 22:23-30
The expression of the mutant p53 tumor suppressor gene was evaluated in 33 human prostate carcinomas. Using an immunohistochemical method with monoclonal antibodies PAb 1801 and PAb 240, 26 (79%) tumors demonstrated positive immunostaining for mutant
Autor:
Dhruv Kumar, Sharmila Shankar, Rajesh Nanta, P J Van Veldhuizen, Daniel Meeker, Rakesh K. Srivastava, Marianna Rodova
Publikováno v:
Oncogenesis
Prostate cancer stem cells (CSCs) are defined by their extensive self-renewal, differentiation and tumor initiation properties. It is now clear that CSCs are involved in tumor growth and recurrence, and resistance to conventional treatments. The soni
Autor:
P J Van Veldhuizen, Sarah A. Taylor
Publikováno v:
American journal of clinical oncology. 19(2)
The development of a chylothorax is a rare complication of a superior vena caval thrombosis. We describe a unique case of chylous pleural effusion occurring in a patient with an underlying lymphoma who had a Hickman-Broviac catheter and a left subcla
Autor:
P J, Van Veldhuizen, A, Wyatt
Publikováno v:
The American journal of gastroenterology. 90(6)
Metoclopramide, a drug with oxidant activity, has infrequently been reported to cause methemoglobinemia in infants. We present a unique case in which a patient on chronic metoclopramide therapy developed sulfhemoglobinemia that resolved with subseque
Publikováno v:
The American journal of the medical sciences. 307(5)
Hypercalcemia is a relatively common problem seen in the presence of malignancy, and is the most common life-threatening metabolic disorder in patients with cancer. In the hospitalized patient, malignancy is the most common cause of hypercalcemia. It